HIGHLIGHTS

INTRODUCTION
Directed differentiation of human pluripotent stem cells offers robust systems to study gene function during human development. Defined and efficient human hepatic differentiation systems have been developed and automated, allowing detailed mechanistic studies to be performed (Hay et al., 2007 (Hay et al., , 2008 Lucendo-Villarin et al., 2017; Meseguer-Ripolles et al., 2018; Rashidi et al., 2018; Si-Tayeb et al., 2010; Sullivan et al., 2010; Szkolnicka et al., 2014) . These models have been sophisticated further using modern genome editing systems. Recently, pluripotent stem cells with an albumin reporter system have facilitated the discovery of key players involved in hepatocyte maturation (Li et al., 2018) . In our study, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) endonuclease nickase was employed for hepatocyte nuclear factor-4alpha (HNF4a) genome editing in human pluripotent stem cells.
HNF4a is a highly conserved transcription factor of the nuclear receptor superfamily (Sladek et al., 1990) . It is a modular protein containing five functional regions. Regions A and B contain the N-terminal transactivation domain (AD-1), region C is a highly conserved zinc finger DNA-binding domain (DBD), region D is a flexible hinge, region E is a multifunctional ligand-binding domain containing the second transactivation domain (AD-2), and the repression region is located in region F (Lau et al., 2018) . Both transactivation domains are important to HNF4a-driven gene transcription (Dhe-Paganon et al., 2002) . To understand which regions of the HNF4a protein are required for directing cell specification and maturation, we used CRISPR-Cas9-based genome editing technology to modify the DBD in the amino terminus, and AD-2 in the carboxy terminus.
Previous genome-wide location analysis revealed that HNF4a was bound to 12% of genes in human hepatocytes, which was greater than other hepatocyte nuclear factors (Odom et al., 2004) . Notably, 42% of the actively transcribed genes occupied by RNA polymerase II were bound by HNF4a, demonstrating its central role in hepatocyte biology (Odom et al., 2004) . More recent researches showed that HNF4a was essential to the formation of hepatic progenitors during human pluripotent stem cell differentiation (DeLaForest et al., 2011 (DeLaForest et al., , 2018 . In these studies, HNF4a was required for the recruitment of RNA polymerase II to genes that were specifically expressed at the hepatic progenitor stage (DeLaForest et al., 2018).
Given its potent activity, HNF4a is regulated at numerous levels, which include nuclear receptor interaction, microRNA (miRNA) regulation, and post-translational modification (Lau et al., 2018; Ramamoorthy et al., 2012; Yokoyama et al., 2011) . A number of post-translational modifications have been shown to regulate HNF4a protein stability, function, and subcellular localization (Jiang et al., 1997; Ktistaki et al., 1995; Viollet et al., 1997; Yokoyama et al., 2011; Zhou et al., 2012) . In addition, recent studies highlighted that HNF4a protein stability is regulated post-translationally through interaction with heat shock protein 90 b interaction (Jing et al., 2017) . In these studies, we were particularly interested in HNF4a 0 s post-translational modification by the Small Ubiquitin-like Modifier (SUMO) at a consensus motif in the AD-2 domain of the carboxy terminus (Zhou et al., 2012) .
This study examined HNF4a protein domain function during hepatoblast and hepatocyte specification from pluripotent stem cells. Isogenic pluripotent stem cell lines, which possessed a truncation or point mutations in HNF4a, were created and compared with a wild-type (WT) line. Pluripotent stem cells that possessed the DNA-binding domain deletion mutant of HNF4a displayed defects in endoderm and hepatic progenitor specification, whereas HNF4a point mutants failed to form functional hepatocytes, with defects in cell metabolism, adhesion, tricarboxylic acid (TCA) cycle flux, miRNA transport, and mRNA processing detected.
RESULTS
Generation and Characterization of HNF4a-Edited Pluripotent Stem Cell Lines
To reduce potential off-target effects, we used paired CRISPR-Cas9 nickases to edit HNF4a (Ran et al., 2013) . Two pairs of Cas9 nickases were utilized to delete the consensus exon 2 in HNF4a ( Figure 1A , top panel). The PCR product from amplification of the targeted region in a homozygous deletion mutant cell line was smaller than the WT control ( Figure 1A , middle panel). There was a 540-and 541-bp deletion in each allele, respectively, which was confirmed by sequencing ( Figure 1A , bottom panel). In parallel, two point mutations (K365R and D367A) were introduced into the SUMOylation consensus motif in the C terminus of HNF4a using Cas9 nickase and a piggyBac-based targeting vector (Zhou et al., 2012; Yusa, 2013) . PCR genotyping followed by sequencing identified the insertion of the selection cassette in the targeted clones. The piggyBac repeats were inserted between 5 0 -and 3 0 -homology arms ( Figure 1B , middle panel). Post removal of the selection cassette, sequencing results confirmed the seamless editing of this locus. In the point mutated clones, two point mutations were introduced into the HNF4a gene (AAG to AGG, K365R; GAC to GCC, D367A). Four synonymous mutations were also introduced to allow the integration of piggyBac (TTAA site) and to disrupt the protospacer-adjacent motif (PAM) sequence for Cas9 nickases ( Figure 1B , bottom panel).
Following genome editing, one WT, one homozygous deletion mutant (DBD Mut), and one point mutated clone (SUMO Mut) were expanded, differentiated, and characterized in detail. Similar to the WT clone, the DBD Mut and SUMO Mut clones possessed typical pluripotent stem cell morphology, more than 90% cells expressed NANOG and OCT4, as well as cell surface markers SSEA4 and TRA-1-60 ( Figures  1C and 1D ). See Table S7 for further details.
Hepatocyte Differentiation Was Perturbed in HNF4a-Edited Pluripotent Stem Cells
To study the effect of editing HNF4a in liver cells, we differentiated WT, DBD Mut, and SUMO Mut clones towards hepatic lineage using a stage-wise differentiation protocol (Meseguer-Ripolles et al., 2018; Wang et al., 2017) . WT human embryonic stem cells transited through definitive endoderm stage (differentiation day 3) (Figures S1A and S1B) and then gave rise to polygonal hepatic progenitors (differentiation day 9) (Figure 2A ). In contrast, the DBD Mut cells displayed cytoplasmic HNF4a, prolonged endoderm differentiation, and failed to commit to hepatoblast lineage, demonstrated by the lack of alpha fetoprotein (AFP) and CCAAT enhancer-binding protein alpha (CEBPA) expression (Figures 2A and S1 ). In contrast, the SUMO Mut cells were comparable to the WT hepatoblast in terms of morphology, demonstrating nuclear HNF4a, albeit with reduced levels of HNF1a, AFP, and CEBPA expression (Figures 2A, 2C , and S1C).
Western bloting demonstrated that the DBD Mut hepatic progenitor cell expressed a truncated form of HNF4a, which was about 10 kDa smaller than the WT or SUMO Mut HNF4a ( Figure 2B ). Sequencing of HNF4a cDNA in the DBD Mut cells confirmed that exons 2 and 3 were skipped in these cells, resulting in the truncated form of HNF4a ( Figure S2 ). A decrease in HNF4a expression was observed in all cell lines between days 9 and 16, which was consistent with previous studies in WT cells (Zhou et al., 2012) ( Figure 2B ). In addition, real-time PCR confirmed higher levels of HNF4a mRNA in the DBD Mut progenitor cells than in the WT or SUMO Mut cells ( Figure 2C ). Despite this, HNF4a in the DBD Mut cells failed to transactivate HNF1a and AFP gene expression and yielded lower levels of transthyretin (TTR) (Figures 2A and 2C ).
In addition, neither the DBD Mut nor the SUMO Mut cells could produce hepatocyte-like cells. Their morphologies were different from each other and the WT control cells ( Figure 2D ). Functionally, the DBD Mut cells had no detectable albumin or AFP secretion, or basal cytochrome P450 (CYP) 3A activity ( Figure 2E ), demonstrating failed hepatoblast and hepatocyte differentiation. The SUMO Mut cells secreted AFP at lower levels than the WT cells; however, they did not exhibit albumin secretion or basal CYP3A activity when hepatocyte specification was induced, demonstrating failed hepatocyte specification ( Figure 2E ). 
Disruption of Cellular Bioenergetics in HNF4a-Edited Cells during Cell Specification
To gain an understanding of the DBD Mut and SUMO Mut cells at the hepatic progenitor stage (day 9), we performed non-targeted profiling of metabolites using 1 H nuclear magnetic resonance metabolomics (Patti et al., 2012) . The metabolic rate for each metabolite was quantified by normalizing the signal intensity against the cell number at the detected time point. The unit for the metabolic rate was then recorded as rate of integral area per cell. Negative and positive rate values indicate consumption and production respectively. The DBD Mut and SUMO Mut cells had a significantly lower consumption rate for both glucose and pyruvate than the WT control ( Figure 3A ). This was confirmed by reduced production rate of lactate, formate, and acetate ( Figure 3A ) and suggests compromised glycolysis and pyruvate oxidation or cycling in both cell lines. In addition, the DBD Mut and SUMO Mut cells possessed a lower consumption rate of the essential amino acids threonine and tryptophan compared with the WT cells ( Figure 3B ). The SUMO Mut cells also demonstrated slower consumption of valine, methionine, and phenylalanine than both WT and DBD Mut cells ( Figure 3B ). Notably, the DBD Mut cells had the highest consumption rate of isoleucine among the three cell types ( Figure S3 ). The WT cells had significantly increased production Table S7 for further details. (C) Real-time PCR quantification of HNF4a, HNF1a, and transthyretin (TTR) mRNA levels in hepatic progenitor stage (day 9) cells. Data were normalized to the housekeeping gene ACTB and expressed relative to the WT cells. The results shown represent three biological replicates, and error bars represent SD. *p < 0.05, ***p < 0.001, ****p < 0.0001; one-way ANOVA with Tukey post hoc test. See Table S8 of alanine and consumption of tyrosine and t-methylhistidine than the other cell lines ( Figure S3 ). These data demonstrated that amino acid metabolism and bioenergetics were disrupted in HNF4a DBD Mut and SUMO Mut cells.
Transcriptomic Analysis of WT and HNF4a-Edited Hepatic Progenitor Stage Cells
The cellular phenotypes we observed highlighted that proper HNF4a function was vital to cell metabolism and hepatocyte specification. To further understand the effect of HNF4a editing on hepatic progenitor cell biology, transcriptomic profiles were generated for WT, DBD Mut, and SUMO Mut cells at differentiation day 9. Principal-component analysis (PCA) of 1,000 genes with the highest variance demonstrated a clear difference among DBD Mut, SUMO Mut, and WT (Figures 4A and S4) . A set of 1,310 differentially expressed genes (DEGs) was defined for further evaluation, which were either differential between the DBD Mut and WT cells or between the SUMO Mut and WT cells (p value <0.05; 2-fold threshold, false discovery rate adjusted; Table S1 ). Gene ontology (GO) enrichment analysis using the Enrichr web server (Chen et al., 2013; Kuleshov et al., 2016) showed that the 452 down-regulated genes unique to DBD Mut cells were enriched in biological processes such as ''sterol import (GO:0035376)'' and ''cholesterol homeostasis (GO: 0042632)'' ( Figure 4B and Table S2 ). Representative genes included apolipoprotein A1 (APOA1), APOA2, and low-density lipoprotein receptor (LDLR) ( Figure 4D and Table S2 ). The expression of a number of significantly down-regulated genes was confirmed by real-time PCR results, including APOA2, APOA4, and 3-hydroxy-3-methylglutaryl-CoA synthase 1 and 2 (HMGCS1 and HMGCS2) ( Figure 4E ). We also detected 215 unique up-regulated genes in the DBD Mut cells. Those were most enriched in pathways like ''transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)'' and ''skeletal system development'' ( Figure 4B and Table S2 ). The representative genes included bone morphogenetic protein 5 (BMP5) and SMAD9 ( Figure 4D and Table S1 ). Interestingly, all up-regulated genes in the DBD Mut cells compared with the WT control showed features for ectoderm differentiation (Table S2) . When combined, these specific DEGs in the Del Mut cells were most enriched in cholesterol homeostasis, Table S8 for further details. extracellular matrix (ECM) organization, alpha-amino acid catabolic process, and cytoskeleton organization regulation (Table S2) . Taken together, the HNF4a DBD domain is essential for the expression of genes important for cell metabolism, ECM, and cytoskeleton organization during hepatoblast specification.
We also analyzed the specific DEGs in the SUMO Mut cells to understand the effect of modifying the HNF4a SUMO motif. We detected 260 down-regulated genes specific to the SUMO Mut cells. Those were enriched for biological processes including ''negative regulation of transcription (GO:0045892)'' and ''regulation of transcription from RNA polymerase II promoter (GO:0006357)'' ( Figure 4C and Table S2 ). Genes such as the forkhead box protein C1 and O3 (FOXC1 and FOXO3) were significantly down-regulated ( Figure 4D and Table S1 ). We also detected 141 up-regulated genes enriched for processes like ''sulfur compound catabolic process (GO:0044273)'' and ''JAK-STAT cascade (GO:0007259)'' ( Figure 4C and Table S2 ). Representative genes included ChaC glutathione-specific gamma-glutamylcyclotransferase 1 (CHAC1) and signal transducer and activator of transcription 4 (STAT4) ( Figure 4D and Table S1 ). Combining the significantly down-and up-regulated genes together, the most enriched biological process was negative regulation of gene transcription (Table S2 ). Collectively, the introduced point mutations in the HNF4a SUMO consensus motif most likely affected gene transcription necessary for successful hepatocyte specification.
We also studied transcriptomic differences between the different mutant forms of HNF4a; 584 genes were down-regulated in the DBD Mut cells when compared with the SUMO Mut. They were mainly enriched in cholesterol homeostasis and lipoprotein remodeling. There were also 242 genes up-regulated in the DBD Mut cells when compared with the SUMO Mut cells. These genes demonstrated a shift towards muscle cell differentiation (Tables S1 and S2 ).
Further analysis revealed that 169 DEGs were down-regulated in both DBD Mut and SUMO Mut cells when compared with the WT. By referring to the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database, the focal adhesion pathway was the only one significantly (p value < 0.05) enriched (Table S2) .
Representative genes encoded proteins for the basement membrane (laminin subunit beta 3), actin binding (filamin A and actinin alpha 4), and ECM binding (collagen type VI alpha 3 chain and talin 1) (Figures 4D  and 4E and Table S1 ). There were also 74 DEGs up-regulated in both the DBD Mut and SUMO Mut cells; however, no pathway was significantly enriched. Therefore focal adhesion alterations in both DBD Mut and SUMO Mut cells probably contributed to hepatoblast and hepatocyte formation.
Proteomic Analysis of WT and HNF4a-Edited Hepatic Progenitor Stage Cells
Following on from the metabolic and transcriptomic studies, we examined alterations in the proteome at differentiation day 9 from WT, DBD Mut, and SUMO Mut lines. Tryptic peptides were analyzed by LC-MS/MS, and the raw MS output data was processed using the MaxQuant platform and then analyzed in Perseus software (Tyanova et al., 2015 (Tyanova et al., , 2016 . A total of 3,639 protein groups were evaluated across all cell types. PCA analysis showed that the DBD Mut cells were distinct from the WT and SUMO Mut cells ( Figure 5A and S5A). Proteins with reduced expression unique to the DBD Mut cells (Table S3) , compared with WT, were involved in metabolic processes and oxidative phosphorylation ( Figure 5B and Table S4 ). Notably, 119 of the 486 less abundant proteins specifically in the DBD Mut cells were mitochondrial proteins (Table S3) . A number of subunits of Complexes I, II, III, IV, and V from the respiratory electron transport chain were down-regulated in the DBD Mut cells ( Figure 5B ). These included the core subunits of Complex I NADH dehydrogenase [ubiquinone] flavoprotein 1 and 2 (NDUFV1 and NDUFV2) and NADH dehydrogenase [ubiquinone] iron-sulfur protein 3 (NDUFS3) ( Figure 5B and Table S3 ). In addition, the most down-regulated proteins in the DBD Mut included mitochondrial HMGCS2 and glycine dehydrogenase (GLDC) ( Table S3 ). HMGCS2 catalyzes the first step of ketogenesis, whereas GLDC is involved in glycine degradation. The decreased expression of HMGCS2 and GLDC was consistent at the mRNA level, together with other metabolic enzymes such as glutamate dehydrogenase 1 (GLUD1) and aldehyde dehydrogenase 5 family member A1 (ALDH5A1) (Figures 4E and S5B) . Taken together, the HNF4a DBD domain is essential to mitochondrial function and cellular metabolism.
Proteins detected at reduced levels in the SUMO Mut cells were significantly enriched for ECM organization and lipoprotein metabolic pathways ( Figure 5C and Table S4 ). A dense network of associations was found around heparan sulfate proteoglycan 2 (HSPG2) in STRING, which is a web resource of known and predicted protein-protein interactions (Szklarczyk et al., 2015) . HSPG2 encodes the perlecan protein, a core component of basement membranes. HSPG2 formed strong associations with the thyroid hormone transporter TTR, apolipoproteins APOA2 and APOA4, and the endocytic receptor low-density lipoprotein receptor-related protein 2 (LRP2), the basement membrane protein nidogen-1(NID1), ECM proteins laminin subunit alpha-1 (LAMA1) and versican (VCAN), and the alpha chain of the coagulation factor fibrinogen (FGA) ( Figure 5C ). Proteins that were more abundant in the SUMO Mut cells were mostly involved in the regulation of protein localization to Cajal body and telomeres ( Figure 5C and Table S4 ). A dense network of associations was also formed by chaperonin-containing T-complex subunits (CCT1-8) ( Figure 5C ). Of note, SUMO Mut cells also contained differentially expressed proteins that were significantly altered for by at least 8-fold (Table S3 ). These proteins were involved in diverse cellular processes, including gluconeogenesis and TCA cycle flux (phosphoenolpyruvate carboxykinase 2 [PCK2]), as well as microRNA transport (Exportin 5). This suggested that the introduced point mutations in HNF4a not only affected ECM organization and cellular metabolism but also led to defects in miRNA transport.
There were 27 commonly down-regulated proteins in the DBD Mut and SUMO Mut cells when compared with the WT control. These proteins were most enriched in KEGG pathways such as complement and coagulation cascades, ECM-receptor interaction, pyruvate metabolism, and TCA cycle (Table S4 ). The representative proteins included pyruvate carboxylase (PC) and PCK2 ( Figure S5C ), which are involved in gluconeogenesis, pyruvate metabolism, and TCA cycle flux, supporting our metabolomic analysis.
Integrating Transcriptomics and Proteomics Datasets
To integrate information from both transcriptomics and proteomics experiments, we re-analyzed both datasets for the edited cells (DBD Mut/WT and SUMO Mut/WT) using a free web-based multiomics data visualization application named PaintOmics 3 (http://bioinfo.cipf.es/paintomics/) (Hernandez-de-Diego et al., 2018) . In the DBD Mut cells, the most enriched KEGG pathway was cholesterol metabolism, followed by pathways in peroxisome proliferator-activated receptor signaling, ECM-receptor interaction, focal adhesion, and amino acid metabolism. Five of the top 10 enriched pathways in the DBD Mut cells were also in the top 10 significantly enriched pathways in the SUMO Mut cells. They were cholesterol metabolism, complement and coagulation cascades, ECM-receptor interaction, focal adhesion, and cell adhesion molecules ( Figure 6A ). Based on these analyses, we summed up the representative proteins that were significantly altered in the DBD Mut cells and in both DBD Mut and SUMO Mut cells ( Figure 6B and Table S3 ). Taken together, the DBD Mut and SUMO Mut cells shared similar dysregulated genes and proteins that function in cellular metabolism and cell-ECM interaction. Meanwhile, the DBD Mut cells had disrupted respiratory electron transport chain and metabolism, highlighting the importance of the HNF4a DBD domain. 
DISCUSSION
The hepatocyte nuclear factor network is vital for mammalian liver development and organ homeostasis (Odom et al., 2006; Watt et al., 2003) . This network controls the expression of a large number of hepatic genes, which perform a broad range of functions (Battle et al., 2006; Bolotin et al., 2010; Odom et al., 2004) . In the present study, we investigated HNF4a function during hepatic specification from human pluripotent stem cells. Without its DNA-binding domain, the truncated form of HNF4a failed to make hepatic progenitor cells, and displayed disruption in key processes such as the respiratory electron transport chain and cellular metabolism. Conversely, the introduction of point mutations, in the C-terminal SUMO consensus motif of HNF4a permitted hepatic progenitor commitment, but led to failed hepatocyte specification. Key genes involved in metabolism, TCA cycle flux, miRNA transport, cell-ECM interactions, mRNA processing, and coagulation cascades were implicated in this study.
Pluripotent stem cells rely heavily on aerobic glycolysis during self-renewal, but they switch quickly to oxidative phosphorylation (OXPHOS) during mesoderm and endoderm differentiation to meet the energy demand. Interestingly, during hepatic differentiation from human pluripotent stem cells, OXPHOS has been reported to decrease when cells reach the hepatic progenitor stage, followed by an increase during hepatocyte maturation (Hopkinson et al., 2017; Jing et al., 2018) . In our study, we integrated omics analyses at the hepatic progenitor stage and found that ketogenesis, amino acid metabolism, TCA flux, and cholesterol metabolism pathways were largely down-regulated in mutated cells. We propose that these alterations were contributory factors that led to failed hepatocyte specification.
Previous studies in rodents have also shown that HNF4a-null embryonic livers display defects in glycogen synthesis (Parviz et al., 2003) . In addition, glucose responsiveness was abolished in murine embryoid-bodyderived visceral endoderm when HNF4a was deleted (Stoffel and Duncan, 1997) . In this study, we demonstrate that HNF4a is critical to glucose utilization at the hepatic progenitor stage ( Figure 3A ). When HNF4a was truncated or point mutated, glucose and pyruvate utilization were compromised ( Figures 3A and S3) . Similarly, PC and PCK2, key enzymes in pyruvate cycling, were significantly down-regulated in genomeedited cells ( Figure 6B ). Notably, the SUMO Mut cells showed more pronounced metabolomic changes than the DBD Mut cells (Figure 3 ). The reason behind this is unknown, but it could be that the knockin mutations affected HNF4a 0 s second transactivation domain (AD-2) leading to alterations in gene transcription.
Although the liver is regarded as one of the body's metabolic centers, less is known about the amino acid metabolism dynamics during early hepatogenesis. A recent study reported that L-valine is essential to murine liver bud growth and promotes the propagation of human hepatic progenitor organoids (Koike et al., 2017) . This study did not investigate whether valine was required for human liver bud formation, but we note that valine consumption was significantly reduced in both DBD Mut and SUMO Mut cells at the hepatic progenitor stage. Although valine was not essential for hepatoblast specification in SUMO Mut cells, it is possible that valine was required for the specification of bipotent hepatic progenitors. However, further research is required to test this hypothesis.
Cell-ECM interaction also play a critical role in cellular differentiation. In the DBD Mut and SUMO Mut hepatic progenitor stage cells, we identified commonly down-regulated genes. They were enriched for focal adhesion and ECM organization pathways (Figures 4 and 6, Supplemental Information, Tables S2 and S4 ). Specific to the SUMO Mut cells, exportin-5 (XPO5) expression was reduced, potentially affecting precursor miRNA transport from the nucleus to the cytoplasm. We also observed down-regulation of genes that regulate gene transcription and mRNA processing, such as FOXC1, FOXO3 ( Figure 4D ), and small nuclear ribonucleoprotein G (SNRPG) (Supplemental Information, Table S3 ). We believe that these data point to deficiencies in multiple cell biological processes that are instrumental in the hepatoblast to hepatocyte transition.
In summary, this study highlights the important role played by HNF4a during hepatic endoderm differentiation. System biology analyses revealed numerous potential regulatory functions for HNF4a. Those include the control of the respiratory electron transport chain, cell metabolism, pyruvate cycling, TCA cycle flux, miRNA transport, mRNA processing, and cell-ECM interaction.
Limitations of the Study
This study was based on an in vitro-directed differentiation system and was not tested in vivo. Table S7 . Related to Figure 1 and 2, Optimised antibody concentrations used in immunostaining, flow cytometry and western blotting.
TRANSPARENT METHODS
Detailed methods are provided in the online version of this paper and include the following:
• KEY RESOURCES 
CONTACT FOR REAGENTS AND SOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, David C. Hay (davehay@talktalk.net).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines H9 female human ESCs were purchased from WiCell. Cells were routinely checked for cell surface markers using flow cytometry and for the presence of mycoplasma.
Cell Culture Conditions H9 human ESCs and genome modified DBD Mut and SUMO Mut cell lines were cultured on Matrigel coated cell culture plates with mTeSR1 medium. Cells were routinely split in 1:3 ratio using Gentle Cell Dissociation reagent. For nucleofection, single cells were obtained by treating the cells with Gentle Cell Dissociation reagent for 7-8 minutes at 37 o C. ROCK inhibitor was used to maintain the single cells.
Hepatocyte Differentiation System
Hepatocyte differentiation of the different cell lines was carried out following lab-developed protocol (Wang et al., 2017) . Briefly, 5 single cells were seeded into per well on 6-well plates coated with LN521/LN111 mix (1:3) for differentiation. Once cells reached approximately 40% confluency post seeding, hepatocyte differentiation was initiated by switching the mTeSR1 medium to RPMI 1640 medium supplemented with 2 % B27 (minus Vitamin A), 100 ng/ml Activin A and 50 ng/ml Wnt 3a. This definitive endoderm induction medium was changed daily for 3 days. Subsequently, the differentiation medium was switched to Knockout DMEM medium supplemented with 20 % knockout serum replacement, 0.5 % GlutaMAX, 1% NEAA and DMSO, and 0.1 mM beta mecaptoethanol. This hepatic progenitor specification medium was changed daily for 5 days. Following this, the differentiation medium was changed to HepatoZYME medium supplemented with 1 % GlutaMAX, 10 uM hydrocortisone, 20 ng/ml hepatocyte growth factor (HGF) and 10 ng/ml oncostatin M (OSM). This hepatocyte-like cells maturation medium was changed every other day for 10 days. The derived hepatocyte-like cells were checked for functions, including basal cytochrome P450 3A activity, albumin and AFP secretion. In addition, cells at representative time points (day 0, day 3, day 9 and day 18) were routinely checked for the expression of typical markers corresponding to that time point.
METHOD DETAILS
CRISPR/Cas9n-sgRNA expression plasmids and targeting vector construction Oligonucleotides for gRNAs (Table S5) targeting HNF4a were annealed and cloned into a BbsI digested Cas9n backbone plasmid (PX462) following a published protocol (Ran et al., 2013) .
The construction of the piggyBac-based targeting construct involved three main steps: the amplification of the 5'-homology arm (HA) and the 3'-HA; the insertion of the 5'-HA into the backbone plasmid; and the insertion of the 3'-HA into the backbone plasmid.
The PCR primers for amplifying 5'-HA and 3'-HA used in Gibson assembly were generated using NEBuilder (https://nebuilder.neb.com) ( Table S5 ). The desired point mutations were incorporated into the primers. The PCR amplification of the two homology arms were catalysed by Q5 high-fidelity DNA polymerase (New England Biolabs). H9 genomic DNA was used as the template for the PCR. The amplified homology arms were then purified before being inserted into the backbone plasmid.
The used piggyBac backbone was a kind gift of Dr. Kosuke Yusa from the Wellcome Trust Sanger Institute, UK. For the insertion of the 5'-HA, the backbone plasmid was digested using NsiI and AscI enzymes and then gel purified. The purified 5'-HA was then inserted using a Gibson assembly reaction. The piggyBac-5'-HA plasmid was then purified and sequenced to confirm the correct insertion of the 5'-HA. Following this, the piggyBac-5'-HA plasmid was digested using HpaI and PacI enzymes and then purified, the 3'-HA was then inserted into the backbone and completed the construction of the donor plasmid. Sequencing was also performed to confirm the correct insertion of the 3'-HA.
Nucleofection of H9 cells
H9 cells at 70-80 % confluency were dissociated using Gentle Cell Dissociation reagent to make single cell suspension. For HNF4a gene knockout, ~ 0.8 million live cells were nucleofected with 3 µg of each Cas9n-sgRNA expression plasmid. For the knockin experiment, ~ 0.8 million cells were nucleofected with 5 µg donor plasmid and 3 µg of both Cas9n-sgRNA expression plasmids. The Human Stem Cell Nucleofector® Kit 1 (Lonza) was used and the nucleofection was facilitated by a Nucleofector 2b device with program A-023 (Lonza).
Selection of the nucleofected cells
48 hours post nucleofection, the cells were selected using 0.5 µg/ml puromycin for 2 days. Puromycin-resistant cells were then propagated and passaged to 10-15 96-well plates at the concentration of 0.8 cell/well in mTeSR1 medium supplemented with 10 µM Rho-associated protein kinase (ROCK) inhibitor (Sigma-Aldrich). At this point, puromycin in the medium for HNF4a knockout experiment cells was removed, but it was kept for selecting cells for HNF4a point mutation knock-in experiment. Following the seeding, the cells were maintained at 37 o C with 10 % CO2 for 7 days to form single cell-derived colonies.
The single-cell derived colonies were picked at about another 5 days later and passaged at a 1:2 ratio to two different plates. ~4 days after the passaging, cells on one plate were lysed for genomic DNA extraction.
Genotyping the single cell-derived colonies
Colonies from HNF4a knockout experiments were analysed using T7EI assay (Table S6 ). The targeted region was PCR amplified and the PCR products were then digested using T7EI enzyme, and subsequently separated on agarose gels and the genotypes were 'readable' on the gel.
Colonies from HNF4a point mutation knock-in experiments were amplified using threeprimer PCRs (Table S6) to differentiate genomic sequences and inserted sequences. The PCR products were separated on agarose gels and the genotype were 'readable' on the gel.
For promising colonies from the DNA gel-based genotyping, the PCR products were purified and then inserted into a pMD19-T vector to form a stable plasmid for sequencing. The colonies with correct genotypes were then saved and expanded to form stable isogenic cell lines.
Removal of the transposon in the HNF4a point mutation knock-in experiment
The correctly targeted colonies were established and two were used for the removal of the selection cassette introduced by the transposon. Briefly, ~0.8 million cells were nucleofected with 5 µg hyperactive PBase (gift from Dr. Kosuke Yusa) and the cells were culture in mTeSR1 medium without puromycin. The cells were then maintained for 3-4 passages before the negative selection mediated by the thymidine analog 1-(2-deoxy-2-fluoro-β-Darabinofuranosyl)-5-iodouracil (FIAU) at a concentration of 200 nM. About 2 weeks after the negative selection, single cell-derived colonies were picked and genotyped as described above.
Immunostaining
Cells were fixed in 100 % ice-cold methanol at -20 o C for 30 minutes. Post fixation, cells were washed three times with DPBS for 5 minutes at room temperature. The cells were subsequently blocked with PBS-0.1 % Tween (PBST) containing 10 % BSA for 1 hour at room temperature. After that, the blocking solution was removed and the respective primary antibody diluted in 1% BSA/PBST was added to the cells. The primary antibody was incubated at 4 o C overnight with gentle agitation. Following this, the used primary antibody solution was removed and the cells were washed three times with PBST for 5 minutes at room temperature. The cells were then incubated with the appropriate secondary antibody diluted in PBST for 1 hours at room temperature in the dark with gentle agitation. The cells were then washed three times with PBST. Following this, cells were stained with DAPI diluted in PBS (1:5000) for 2 minutes at room temperature. The DAPI solution was then removed and the cells were washed twice with PBST. In all cases, the stained cells were stored at 4 o C in the dark before imaging. The primary and secondary antibodies are listed in supplemental Table  S7 .
All images were collected at room temperature using the automated Operetta fluorescent microscope. The images were processed using Columbus Image analysis server.
Flow cytometry
Fluorescence activated cell sorting (FACS) was used to confirm the expression of cell surface markers in hESCs. hESCs from a well on a 6-well plate were washed once with 2 ml DPBS and then dissociated with 1ml TrypLE. The cells were lifted off as single cells and collected. Post centrifugation, cells were resuspended in DPBS and filtered through a 0.22 µm filter. The single cell suspension was then incubated with the fluorochrome conjugated antibodies and the corresponding IgG controls for 30 minutes at 4 o C. The antibody information is listed in supplemental Table S7 . Cells were then washed twice with DPBS, removing any unbound antibody, and span down at 200 x g for 5 minutes. Following this, cells were resuspended in 300 µl of DPBS.
Dead cells and debris were not included in the analysis. This was carried out by using an electronic live gate on forward scatter and side scatter parameters. Data for 20,000-50,000 'live' events were acquired for each sample using a BD LSR Fortessa (4 laser) analyser. The data was analysed using FlowJo software.
Western blotting
Cells at different time points were washed once with DPBS and lysed in wells at room temperature in dark for 5 min. 200 µl home-made SUMO lysis buffer (2 % SDS, 50 mM Tris-HCL (pH 8.0), 1 mM EDTA, 10 mM iodoacetamide) supplemented with proteinase and phosphatase inhibitors (Sigma-Aldrich) at 1 % final concentration was used for each well of a 6-well plate. The cell extract was briefly sonicated using a Bioruptor (Diagenode) and span down for 15 min at 12,000 rpm at 4 o C. The protein supernatant was then transferred to a new 1.5 ml Eppendorf tube.
The Pierce bicinchoninic acid (BCA) assay kit (Thermo Fisher Scientific) was used to quantify the protein concentration. Protein supernatant was diluted 1:10 using the lysis buffer. 20 µl protein supernatant of each sample was analysed in duplicates. Reagent A and B from the kit were mixed at a 1:50 ratio and a volume of 200 µl was transferred into each sample well. A standard curve was generated using the bovine serum albumin standards at concentrations ranging from 0-2000 µg/ml. The plate was incubated at room temperature for 30 min and the absorbance was read at 562 nm. The protein concentrations were calculated by linear extrapolation using the standard curve generated.
The SDS-NuPAGE polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate proteins of different sizes. 50 μg protein supernatant was denatured at 100 o C for 10min in 1x NuPAGE LDS sample buffer supplemented with 10 mM DTT before being used for electrophoresis. 4-12 % Bis-Tris precast polyacrylamide gels (Thermo Fisher Scientific) were used with the XCell SureLock Mini-Cell System (Thermo Fisher Scientific) for the electrophoresis. Once the gel was fitted in the chamber, the tank was filled with 1x NuPAGE MES-SDS running buffer with 0.5 ml of NuPAGE Antioxidant (Thermo Fisher Scientific) added into the inner chamber. The samples were loaded along with a SeeBlue Plus 2 Pre-Stained Standard (Invitrogen). A current of 200 V was applied and the samples were run for 1-2 hours depending on the purpose of each experiment. The gels containing proteins were carefully removed from the cassette and were used in western blotting.
Following the protein separation using SDS-PAGE gels, the proteins were then transferred from the gels to the Polyvinylidene fluoride (PVDF) membrane. The transfer sack was assembled in the following order from cathode to anode: 3x sponge; 2x filter paper soaked in 1x NuPAGE Transfer Buffer; SDS-PAGE gel; PVDF membrane activated in 100 % ice-cold methanol; 2x filter paper soaked in 1x NuPAGE Transfer Buffer; 3x sponge. No bubbles between the gel and the membrane were allowed. Once the sack was assembled and placed into the XCell Blot II module, the module was then tightly sealed and placed into the transfer SureLock tank containing 1x transfer buffer in the inner chamber and ice-cold water in the outer chamber. The tank was then placed on ice for the entire protein transfer process. A constant current of 160mA was applied for 90-120 min.
Once the proteins were successfully transfer onto the PVDF membrane, the membrane was blocked in 10 % skimmed milk at room temperature with gentle agitation for at least one hour to prevent non-specific antibody binding.
Following this, the membrane was probed with desired primary antibody diluted in 5 ml 10 % BSA/PBST at 4 o C overnight with gentle rolling. The dilution ratios were optimised specifically for each primary antibody and were listed in Table 4 . Unbound antibody was removed by three, 5-min washes with adequate 0.1 % PBST at room temperature with agitation. The primary antibody could be re-used for 2-3 times if stored at 4 o C properly.
After probed with the primary antibody, the membrane was then incubated with corresponding horseradish peroxidase (HRP)-conjugated secondary antibody diluted in 5 ml 10 % skimmed milk at room temperature for at least one hour with gentle rolling. Unbound secondary antibody was then removed by three, 5-min washes with adequate 0.1 % PBST at room temperature with agitation. The primary and secondary antibody information is listed in supplemental Table S7 .
The proteins of interest were then detected using enhanced chemiluminescence (ECL). Proteins bands were visualised using the Pierce Enhanced Chemiluminescence Kit (Pierce, UK). Peroxidase buffer and the Luminol/Enhancer solution was mixed at a 1:1 ratio and spread evenly onto the membrane (2 ml for each membrane), followed by a 5-min incubation at room temperature. The HRP substrate reacts with the conjugated HRP group presented on the secondary antibody, specifying the target protein. The membrane was developed in the dark room using a film developer.
ELISA quantification
At the hepatocyte stage, day 18 cell culture supernatants were collected. Albumin and AFP concentration were determined using commercially available kits (Alpha Diagnostic Intl. Inc, San Antonio, USA). The ELISA assay was performed according to the manufacturer's instructions with cell culture supernatants diluted at 1:3 (albumin) or 1:10 (AFP). After one hour incubation at room temperature, the wells were washed for four times and anti-human albumin or AFP HRP-conjugated secondary antibodies were added to the wells for 30 minutes. Subsequently, the wells were washed five times and the substrate was then added and incubated for a further 15 minutes in the dark at room temperature. Following this, the stop solution was added directly to the wells in order to stop the enzymatic reaction. The plates were then read at 450 nm with a reference wavelength of 630nm using a FLUOstart Omega plate reader (BMG LabTech, Germany). Blank cell culture media incubated at 37 o C for 48 hours, diluted in 1:3 or 1:10 was used as a negative control. The data was then normalised to per ml per 48 hours per mg protein as determined by BCA assay (Pierce, UK).
Quantitative real-time PCR
Total RNA was collected from cells using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Total RNA was reverse transcribed using QuantiTect reversetranscription kit (Qiagen) following the manufacturer's protocol. Real-time PCR was performed using TaqMan Fast Universal Master Mix and appropriate Taqman probes (Applied Biosystems). The primers are listed in supplemental Table S8 . The samples were analysed using Roche LightCycler 480 Real-Time PCR System. Results were normalized to beta-actin. The qPCRs were run in triplicates.
CYP3A assay
Day 18 hESC-derived hepatocyte-like cells (HLCs) were incubated with the luciferin conjugated CYP3A (1:40) substrate (P450 P-Glo Luminescent Kit, Promega, UK) diluted in the maturation medium for 5 hours at 37 o C. Blank cell culture medium was used as a negative control. The supernatants were then collected and tested for luminescence. The luciferin detection reagent was reconstituted by mixing the buffer with the lyophilised luciferin detection reagent. 50 µl of the collected supernatant was mixed with 50 µl of the detection reagent in a white 96 well plate and incubated at room temperature in the dark for 20 minutes. The relative levels of basal activity were measured using a luminometer (POLARstar optima). Units of activity were recorded as relative light units per ml per mg protein (RLU/ml/mg) as normalised by protein content.
